Neurobiology of Aging
Volume 32, Issue 12 , Pages 2183-2189 , December 2011

Blood–brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy

  • Sook K. Song

      Affiliations

    • Department of Neurology and Brain Research Institute, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Seung-Koo Lee

      Affiliations

    • Department of Radiology, Yonsei University College of Medicine, Seoul, South Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Jae Jung Lee

      Affiliations

    • Department of Neurology and Brain Research Institute, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Ji E. Lee

      Affiliations

    • Department of Neurology and Brain Research Institute, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Hyun Seok Choi

      Affiliations

    • Department of Radiology, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Young H. Sohn

      Affiliations

    • Department of Neurology and Brain Research Institute, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Phil Hyu Lee

      Affiliations

    • Department of Neurology and Brain Research Institute, Yonsei University College of Medicine, Seoul, South Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea
    • Corresponding Author InformationCorresponding author at: Department of Neurology, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul 120-752, South Korea. Tel.: +82 2 2228 1608; fax: +82 2 393 0705.

Received 6 October 2009 ,Revised 13 December 2009 ,Accepted 21 December 2009.

References 

  1. Bartels AL, Willemsen AT, Kortekaas R, de Jong BM, de Vries R, de Klerk O, et al. Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson's disease PSP and MSA. J. Neural Transm. 2008;115:1001–1009
  2. Bartels AL, Kortekaas R, Bart J, Willemsen AT, de Klerk OL, de Vries JJ, et al. Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol. Aging. 2009;301:1818–1824
  3. Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF. Blood–brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology. 2007;68:1809–1814
  4. Desai BS, Monahan AJ, Carvey PM, Hendey B. Blood–brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant. 2007;16:285–299
  5. Farrall AJ, Wardlaw JM. Blood–brain barrier: ageing and microvascular disease—systematic review and meta-analysis. Neurobiol. Aging. 2009;30:337–352
  6. Gao HM, Hong JS. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 2008;29:357–365
  7. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci. 1999;163:94–98
  8. Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T. Microglial activation parallels system degeneration in multiple system atrophy. J. Neuropathol. Exp. Neurol. 2004;63:43–52
  9. Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, et al. Blood–brain barrier dysfunction in parkinsonian midbrain in vivo. Ann. Neurol. 2005;57:176–179
  10. Lim TS, Lee PH, Kim HS, Yong SW. White matter hyperintensities in patients with multiple system atrophy. J. Neurol. 2009;256:1663–1670
  11. Ludemann L, Hamm B, Zimmer C. Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging. Magn. Reson. Imaging. 2000;18:1201–1214
  12. Miller VM, Kalaria RN, Hall R, Oakley AE, Kenny RA. Medullary microvessel degeneration in multiple system atrophy. Neurobiol. Dis. 2009;26:615–622
  13. O'Sullivan M. Leukoaraiosis. Pract. Neurol. 2008;8:26–38
  14. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J. Magn. Reson. Imaging. 2002;16:407–422
  15. Popescu BO, Toescu EC, Popescu LM, Bajenaru O, Muresanu DF, Schultzberg M, et al. Blood–brain barrier alterations in ageing and dementia. J. Neurol. Sci. 2009;283:99–106
  16. Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karlsson I, et al. A population study on blood–brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology. 1998;50:966–971
  17. Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning GK. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov. Disord. 2007;22:2196–2203
  18. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging. 1999;10:223–232
  19. Ubhi K, Lee PH, Adame A, Inglis C, Mante M, Rockenstein E, et al. Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy. J. Neurosci. Res. 2009;87:2728–2739
  20. Vanacore N, Bonifati V, Fabbrini G, Colosimo C, De Michele G, Marconi R, et al. Case–control study of multiple system atrophy. Mov. Disord. 2005;20:158–163
  21. Wang H, Golob EJ, Su MY. Vascular volume and blood–brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls. J. Magn. Reson. Imaging. 2006;24:695–700
  22. Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3:93–103
  23. Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG. Multiple system atrophy: a primary oligodendrogliopathy. Ann. Neurol. 2008;64:239–246
  24. Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, et al. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov. Disord. 2004;19:1391–1402
  25. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology. 2008;71:804–811

PII: S0197-4580(10)00002-3

doi: 10.1016/j.neurobiolaging.2009.12.017

Neurobiology of Aging
Volume 32, Issue 12 , Pages 2183-2189 , December 2011

Article Tools

* Image Usage & Resolution